BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37415737)

  • 41. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
    Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
    J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling.
    Wang J; Feng W; Dong Y; Mao X; Guo F; Luo F
    Oncol Rep; 2018 Dec; 40(6):3654-3662. PubMed ID: 30272336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
    Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
    Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J; Liu C; Shi J; Wen K; Wang X
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Li Y; Liu Y; Shi F; Cheng L; She J
    Oncol Res; 2016; 24(5):287-293. PubMed ID: 27712585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
    Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
    J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway.
    Liu G; Yang S; Liu Y; Xu Y; Qiu H; Sun J; Song J; Shi L
    Int J Clin Oncol; 2022 May; 27(5):911-920. PubMed ID: 35122587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Ag-1031 on apoptosis in gastric cancer AGS cells and its effects on the PI3K/AKT/mTOR signaling pathway.
    Dai J; Liu D; Chen L; Sun L
    Biotechnol Lett; 2020 Nov; 42(11):2447-2452. PubMed ID: 32651704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of SDCBP inhibits cell proliferation and induces apoptosis by regulating PI3K/AKT/mTOR pathway in gastric carcinoma.
    Qian B; Yao Z; Yang Y; Li N; Wang Q
    Biotechnol Appl Biochem; 2022 Feb; 69(1):240-247. PubMed ID: 33432665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling.
    Shi L; Wu Z; Miao J; Du S; Ai S; Xu E; Feng M; Song J; Guan W
    Mol Biol Cell; 2019 Sep; 30(19):2527-2534. PubMed ID: 31339445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA ncRuPAR regulates gastric cancer cell proliferation and apoptosis via phosphoinositide 3-kinase/protein kinase B signaling.
    Xu R; Yu J; Song S; Sun D; Xiu L; Xu J; Zhao J; Liu X; Ji Q; Yue X
    Int J Med Sci; 2022; 19(13):1835-1846. PubMed ID: 36438913
    [No Abstract]   [Full Text] [Related]  

  • 57.
    Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
    Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
    Qiu P; Li X; Gong M; Wen P; Wen J; Xu L; Wang G
    Can J Gastroenterol Hepatol; 2023; 2023():2021515. PubMed ID: 36967718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
    Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
    Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.